Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries

Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries

Data from a large multicenter observational study of patients with multidrug-resistant tuberculosis (MDR TB) were analyzed to simulate the possible use of 2 new approaches to treatment of MDR TB: a short (9-month) regimen and a bedaquiline-containing regimen. Of 1,254 patients, 952 (75.9%) had no re...

Full description

Bibliographic Details
Main Authors: Ekaterina V. Kurbatova, Tracy Dalton, Julia Ershova, Thelma E. Tupasi, Janice Campos Caoili, Martie L. van der Walt, Charlotte L. Kvasnovsky, Martin Yagui, Jaime Bayona, Carmen Contreras, Vaira Leimane, Laura E. Via, HeeJin Kim, Somsak Akksilp, Boris Y. Kazennyy, Grigory V. Volchenkov, Ruwen Jou, Kai Kliiman, Olga V. Demikhova, J. Peter Cegielski
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-06-01
Series:Emerging Infectious Diseases
Subjects:
multidrug-resistant tuberculosis
second-line drug resistance
tuberculosis and other mycobacterial infections
antimicrobial resistance
bacteria
tuberculosis
Online Access:https://wwwnc.cdc.gov/eid/article/21/6/14-1329_article

Internet

https://wwwnc.cdc.gov/eid/article/21/6/14-1329_article

Similar Items